돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 710068생성일: 2026년 10월 25일

Cesium carbonate → (S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-((pyridazin-4-yloxy)methyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanone

https://huagongshe.com/reaction/710068

반응식

참여 물질

역할이름HCID투입량
반응물Cesium carbonateHCID 10796—
반응물(1,1'-Binaphthalen)-2-yldi-tert-butylphosphineHCID 2734941—
반응물4-Bromopyridazine hydrobromideHCID 53407906—
반응물(S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-(hydroxymethyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanoneHCID 86706747—
촉매palladium(II) acetateHCID 167845—
용매TolueneHCID 1140—
생성물(S)-2,2-Difluoro-2-(1-hydroxy-3,3,5,5-tetramethylcyclohexyl)-1-(2-(5-((pyridazin-4-yloxy)methyl)isoxazol-3-yl)pyrrolidin-1-yl)ethanoneHCID 8670678116.7%

반응 조건

온도100 °C

반응 단계

A sealed tube was charged with a mixture prepared by adding toluene (2 ml) to Compound 18 (30 mg), 4-bromopyridazine hydrobromide (22 mg), Pd(OAc)2 (2 mg), Cs2CO3 (37 mg), and [1,1′-binaphthalen]-2-yldi-tert-butylphosphine (3 mg) and the mixture was stirred at 100° C. for 4 hours. After cooling the reaction mixture to room temperature, NH silica gel was added, followed by stirring for a while. After separating the silica gel by filtration, the silica gel was washed with chloroform and the solvent was distilled off; the resulting residue was purified by reverse-phase preparative HPLC to give the titled compound (6.0 mg, colorless oil.)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09181229B2
출처 데이터셋uspto-grants-2015_11
ORD IDord-a77022a34471403ea39f5d751aafaa39
출처 메모uspto-grants-2015_11